Stock Performance and Market Context
On the day of this record high, Integrated Proteins Ltd outperformed its sector, the solvent extraction segment, which declined by 4.41%. The stock recorded a positive day change of 0.51%, contrasting with the broader Sensex index’s decline of 1.02%. Over the past week, the stock has gained 8.69%, while the Sensex fell by 2.31%, underscoring the stock’s resilience amid broader market weakness.
More impressively, the stock has been on a consecutive seven-day winning streak, delivering a cumulative return of 12.91% during this period. This momentum is supported by the stock trading above all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a robust bullish trend.
Long-Term Returns Outshine Benchmarks
Integrated Proteins Ltd’s price trajectory over longer horizons highlights extraordinary growth relative to the Sensex. The stock’s 3-month return stands at 297.83%, compared to the Sensex’s negative 10.08%. Year-to-date, the stock has surged 241.86%, while the Sensex has declined 11.71%. Over one year, the stock’s return is 159.37%, contrasting with the Sensex’s 8.72% loss.
Over a three-year span, Integrated Proteins Ltd has delivered a staggering 1,076.00% return, dwarfing the Sensex’s 21.30% gain. The ten-year performance is even more striking, with the stock appreciating by 5,395.33%, compared to the Sensex’s 191.74%. These figures illustrate the company’s exceptional value creation over the long term within the edible oil sector.
Valuation Metrics Reflect Elevated Market Expectations
At the current price of Rs.117.60, valuation multiples indicate a premium positioning. The trailing twelve-month price-to-earnings (P/E) ratio stands at 663x, reflecting high market expectations despite the company’s modest earnings. Price-to-book value is 10.76x, while enterprise value to EBITDA and EBIT both register at 218.95x, signalling a stretched valuation relative to earnings and operating cash flow.
Enterprise value to sales is 8.52x, and EV to capital employed matches the P/BV at 10.76x. Dividend metrics are not applicable as the company has not declared dividends recently. These valuation figures suggest investors are pricing in significant growth or strategic value, despite the company’s current earnings profile.
Technical Analysis Confirms Bullish Momentum
The overall technical trend for Integrated Proteins Ltd is bullish, a shift that occurred on 27 March 2026 when the stock was trading at Rs.71.33. Key technical indicators support this positive momentum: the MACD is bullish on both weekly and monthly charts, Bollinger Bands signal bullishness, and moving averages confirm upward momentum.
While the weekly RSI shows bearishness, the monthly RSI remains neutral, and the KST indicator is mildly bearish on the monthly scale but bullish weekly. Dow Theory also supports a bullish outlook. Immediate support is at the 52-week low of Rs.20.71, with resistance levels previously at Rs.99.56 (20-day moving average) and Rs.53.16 (100-day moving average) now surpassed, culminating in the new all-time high at Rs.117.60.
Delivery Volumes Indicate Strong Market Participation
Recent delivery volumes have shown a notable increase, with a 1-day delivery change of 102.83% compared to the 5-day average, and a 1-month delivery volume increase of 22.75%. On 11 May 2026, the volume was 6.28 thousand shares, doubling the 5-day average of 3.1 thousand and significantly above the previous month’s average of 2.69 thousand. This heightened activity reflects increased trading interest coinciding with the stock’s price rise.
Quality Assessment Highlights Mixed Fundamentals
Integrated Proteins Ltd’s overall quality grade is below average, reflecting certain financial and operational challenges. Management risk is rated below average, while growth is average. Capital structure is also below average, though the company maintains negligible debt with an average debt to EBITDA ratio of 0.46 and zero net debt to equity, indicating low leverage.
Sales growth over five years is robust at 92.87%, but EBIT growth is modest at 7.26%. The average EBIT to interest ratio is weak at -0.05x, and return on capital employed (ROCE) and return on equity (ROE) are low at -5.14% and 1.51% respectively. The company has no promoter share pledging and institutional holdings are minimal.
Short-Term Financial Trends Remain Flat
As of December 2025, the short-term financial trend is flat. The quarterly earnings per share (EPS) recorded the lowest value at Rs.-0.06, indicating limited profitability in the recent quarter. Despite this, the stock’s price performance and technical indicators have remained strong, suggesting market valuation is driven by factors beyond immediate earnings.
Summary of Integrated Proteins Ltd’s Market Milestone
Integrated Proteins Ltd’s attainment of an all-time high price of Rs.117.60 on 12 May 2026 represents a significant achievement in its market journey. The stock’s sustained gains over multiple timeframes, strong relative performance against the Sensex and sector peers, and bullish technical indicators underscore a period of notable strength. While valuation multiples are elevated and quality metrics indicate areas for improvement, the company’s long-term sales growth and low leverage provide a foundation for its current market standing.
This milestone reflects the culmination of a multi-year upward trajectory, with the stock delivering exceptional returns over three and ten-year periods. The recent surge in delivery volumes and consistent price appreciation highlight active market engagement and confidence in the stock’s positioning within the edible oil sector.
